J&J Hit With $417M Verdict In 1st Calif. Talc Cancer Trial
The first California state jury to evaluate the possible link between Johnson & Johnson's talcum powder products and ovarian cancer set a high-water mark on Monday with a $417 million verdict...To view the full article, register now.
Already a subscriber? Click here to view full article